Today’s cyclodextrin:
I rarely see something new in the cyclodextrin field. But happened last week.
This innovation used methyl-BCD as an active ingredient for inhalation therapy for lung cancer. Each area – using CDs as anticancer agents and using them in inhalation as actives – has been known, yet this combined approach is certainly novel.
Congratulations to the inventors: Laurent Yvan-Charvet, Marius Ilié, Paul Hofman.
WO2024246220 METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER
